Cell and gene therapy for inherited deficiency of bilirubin glucuronidation

Journal of Perinatology

Volumn 16, Issue 3 PART 2, 1996, Pages

  Kim, Byung Ho ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIRUBIN GLUCURONATE; BILIRUBIN GLUCURONOSIDE GLUCURONOSYLTRANSFERASE; DRUG DERIVATIVE; GLUCURONOSYLTRANSFERASE;

ANIMAL; BIOLOGICAL THERAPY; CRIGLER NAJJAR SYNDROME; ENZYMOLOGY; GENE THERAPY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; RAT; REVIEW; SURVIVAL RATE;

ANIMALS; BILIRUBIN; CRIGLER-NAJJAR SYNDROME; GENE THERAPY; GLUCURONOSYLTRANSFERASE; HUMANS; RATS; SURVIVAL RATE; TISSUE THERAPY;

EID: 0030135815     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Roy-Chowdhury J, Wolkoff AW, Roy-Chowdhury N, et al. Hereditary jaundice and disorders of bilirubin metabolism. In: Scriver CR, Boudet AL, Sly WS, Valle, editors. The metabolic basis of inherited disease. 7th ed. New York: McGraw Hill, 1995:2161-208.
2. Bosma PJ, Seppen J, Goldhoorn B, et al. Bilirubin UDP-glucuronosyl-transferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994;269:17960-4.